D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q2 2026 holdings
- Shares (Q2 2026)
- 710,559
- Value
- $44.7M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 710,559 | $44.7M | <0.1% | −80,587−10.2% | Reduced | Holders |
| Q1 2026 | 791,146 | $55.5M | <0.1% | +175,990+28.6% | Added | Holders |
| Q4 2025 | 615,156 | $50.4M | <0.1% | +16,849+2.8% | Added | Holders |
| Q3 2025 | 598,307 | $35.6M | <0.1% | −124,876−17.3% | Reduced | Holders |
| Q2 2025 | 723,183 | $29.3M | <0.1% | +312,507+76.1% | Added | Holders |
| Q1 2025 | 410,676 | $21.1M | <0.1% | +45,132+12.3% | Added | Holders |
| Q4 2024 | 365,544 | $20.2M | <0.1% | +183,449+100.7% | Added | Holders |
| Q3 2024 | 182,095 | $5.99M | <0.1% | −87,698−32.5% | Reduced | Holders |
| Q2 2024 | 269,793 | $7.33M | <0.1% | +73,281+37.3% | Added | Holders |
| Q1 2024 | 196,512 | $7.14M | <0.1% | +155,985+384.9% | Added | Holders |
| Q4 2023 | 40,527 | $820.7K | <0.1% | +40,527 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −23,451−100.0% | Sold out | Holders |
| Q2 2023 | 23,451 | $423.8K | <0.1% | +5,884+33.5% | Added | Holders |
| Q1 2023 | 17,567 | $220.8K | <0.1% | +17,567 | New | Holders |